Our skin is the largest organ in the human body, and can be affected by a multitude of different conditions and diseases. These can have profound – and in some cases, debilitating – effects on patients’ physical, functional, and emotional well-being.
The 2010 National Ambulatory Medical Care Survey reports that there are approximately 56 million annual office visits for medical dermatology conditions in the United States alone. And according to VisionGain, the medical dermatology market is expected to approach $25.5 billion in global revenues in 2015.
While the current standards of care for many dermatological conditions offer benefits and temporary relief to patients, they also possess many limitations and possible side effects, such as such as dryness, stinging, burning, and photosensitivity.
Klox Technologies has developed its proprietary and non-invasive dermatological treatment solutions to address acne vulgaris and cosmetic skin care. However, we also believe that our BioPhotonic technology platform can be effective in the treatment of other inflammatory skin diseases, such as psoriasis, eczema, and rosacea. The nature of these pathologies suggest that they may benefit from a combination of increased collagen production, modulation of cellular response, and the production of photons and bactericidal activity.